Recommendations

Published on March 2017 | Categories: Documents | Downloads: 24 | Comments: 0 | Views: 253
of 2
Download PDF   Embed   Report

Comments

Content

CEOs must invest in new means of identifying products as genuine that cannot be duplicated with 3D printers, such as embedded chips with unique signal characteristics. ¦ CEOs and CIOs at manufacturers and retailers must team up to identify more effec tive means for consumers to validate that products are genuine. ¦ Chief marketing officers (CMOs) should make easily duplicated products accessibl e for 3D printing so consumers can print personalized copies, but only after understandin g the legal ramifications of consumer-printed copies that fail or injure someone. Related Research: "Cool Vendors in 3D Printing, 2013" "Use the Gartner Business Model Framework to Determine the Impact of 3D Printing " "Gartner Invest/Research Community Vision: Assessing the Revolutionary Potential of 3D Printing" "Seven Strategies to Boost Technology Innovation" Strategic Planning Assumption: By 2016, 3D printing of tissues and organs (biopr inting) will cause a global debate about regulating the technology or banning it for both human and nonhuman use. Analysis By: Daryl Plummer, Pete Basiliere 3D printing represents a different kind of disruption from other IT-related tech nologies in that it affects things largely centered on the physical world rather than the digital on e. In this regard, the use of digital resources to shape our physical reality can also have the effect of shaping our fears of personal impact. The emergence of 3D bioprinting facilities with the ability to print human organs can leave people wondering what will be the effect on society. Many questions wi ll be raised such as "Who will control the ability to receive bioprints?," "Who will ensure the qu ality of the organs?" and "Will there be regulation of this emerging industry?" However, beyond the fears, there is the reality of what 3D bioprinting means in terms of helping people who need organs that are otherwise not readily available. Here, we examin e a number of issues surrounding the good and bad of 3D bioprinting. Key Findings: ¦ There will be rapid technological advances in bioprinting without widespread und erstanding and acceptance of the ramifications of the technology. People will be fully aware by 2016, sparking a spirited debate about the ethical, moral, political and religious aspects of b ioprinting. ¦ Not all advances will be universally received as good or positive uses of biopri nting technology, especially when "enhanced" organs such as replacements of a patient's organ made from his or her stem cells in combination with animal cells are printed. ¦ The general public and many politicians will view the difference between printin g enhanced organs and genetically modifying food crops as nonexistent, at least from a gove rnmental policy and moral perspective, igniting the debate on bioprinting. Near-Term Flag: The U.S. Food and Drug Administration (FDA) or a comparable agen cy in a

developed nation that is charged with evaluating all medical proposals will intr oduce guidelines that prohibit the bioprinting of life-saving 3D printed organs and tissues without it s prior approval by the end of 2015.

Sponsor Documents

Or use your account on DocShare.tips

Hide

Forgot your password?

Or register your new account on DocShare.tips

Hide

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close